Completed PHASE4 INTERVENTIONAL 3-arm NCT02468323

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia (PONV)

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia: Study Single Center, Prospective, Double-blind, Randomized, Placebo Controlled

Sponsor: Hospital de Base

Conditions PONV

Interventions Ondansetron Palonosetron Placebo

Updated 8 times since 2017 Last updated: Mar 8, 2017 Started: Oct 31, 2015 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on PONV, this trial is completed. The trial is conducted by Hospital de Base and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Apr 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Feb 2017 — Apr 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital de Base

Data source: Hospital de Base

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brasília, Brazil